“Armoring” CAR T Cells Bolsters Activity against Solid Tumors

Two recent studies of CAR T cells targeting tumor-associated macrophages have shown that "armoring" these engineered cells with the ability to express the cytokine IL12 makes them more effective at eradicating solid tumors and leads to sustained remodeling of the immunosuppressive tumor microenvironment.